Are FDA and CE sacrificing safety for a faster commercialization of xenogeneic tissue devices? Unavoidable need for legislation in decellularized tissue manufacturing.
作者信息
Naso F, Iop L, Spina M, Gerosa G
机构信息
Department of Cardiac, Thoracic and Vascular Sciences, University Hospital of Padova, Padova, Italy.
出版信息
Tissue Antigens. 2014 Mar;83(3):193-4. doi: 10.1111/tan.12275. Epub 2014 Jan 7.
PMID:24397352
Abstract
摘要
Zotero 插件